Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -6.54 |
| peg ratio | 0.13 |
| price to book ratio | 4.83 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -6.90 |
| price fair value | 4.83 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -59.34% |
| return on equity | -74.86% |
| return on capital employed | -66.5% |
liquidity ratios | |
|---|---|
| current ratio | 13.64 |
| quick ratio | 13.64 |
| cash ratio | 2.53 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | -16,483.07 |
| cash conversion cycle | 16,483.07 |
| receivables turnover | 0.00 |
| payables turnover | -0.02 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.12 |
| debt equity ratio | 0.15 |
| long term debt to capitalization | 0.13 |
| total debt to capitalization | 0.13 |
| interest coverage | -33.98 |
| cash flow to debt ratio | -3.91 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.11 |
| cash per share | 8.35 |
| operating cash flow per share | -4.10 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.91 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -475.97 |
Frequently Asked Questions
When was the last time Vera Therapeutics, Inc. (NASDAQ:VERA) reported earnings?
Vera Therapeutics, Inc. (VERA) published its most recent earnings results on 07-05-2026.
What is Vera Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vera Therapeutics, Inc. (NASDAQ:VERA)'s trailing twelve months ROE is -74.86%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vera Therapeutics, Inc. (VERA) currently has a ROA of -59.34%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VERA's net profit margin stand at?
VERA reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VERA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 13.64 in the most recent quarter. The quick ratio stood at 13.64, with a Debt/Eq ratio of 0.15.